Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 70 recruiting now full pipeline #15 of 28,963 conditions

Asthma: full-pipeline trial registry

70 of 378 indexed Asthma trials are currently recruiting.

Corpus placement: #15 of 28,963 conditions by registered trial count.

378 US clinical trials · 70 currently recruiting · #15 of 28,963 conditions by registered trial count

Asthma: 378 US clinical trials tracked, 70 recruiting.

Asthma is the subject of 378 registered US clinical trials on ClinicalTrials.gov, 70 of them currently open to new participants. 89 are in Phase 3-4 (later-stage) and 108 in Phase 1-2 (earlier-stage). The most active sponsor is GlaxoSmithKline, running 24 of these trials.

Open enrollment snapshot

Asthma has 378 registered US clinical trials, 70 of them open to new participants right now, about 19% of the total.

70
recruiting participants now
19%
of trials open to enrollment
89
in Phase 3-4 (later-stage)
24
top sponsor: GlaxoSmithKline

Corpus placement: #15 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.

Key findings

What ClinicalTrials.gov does not surface for Asthma on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.

  1. Asthma is recruiting below its size-band peers.

    70 of 378 indexed trials (18.5%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Asthma trials is spread across many organizations.

    GlaxoSmithKline accounts for 24 of 378 trials (6.3%). 161 distinct sponsors appear on at least one study for this condition label.

  3. Typical Asthma enrolment sits around 144 participants.

    Median target enrolment is 144 among the 375 trials that report a genuine target (sentinel values excluded). 160 of those (42.7%) plan for fewer than 100 participants.

  4. Asthma research is mostly interventional.

    298 interventional and 80 observational studies make up this index (78.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 127Phase 281Phase 351Phase 438

Open and recent trials

378 total, page 5 of 8

COMPLETED 224 participants

ICATA Asthma Mechanistic Study

National Institute of Allergy and Infectious Diseases (NIAID)

NCT00377390

COMPLETED Phase 3 223 participants

Asthma Action at Erie Trial

University of Illinois at Chicago

NCT02481986

COMPLETED NA 222 participants

Asthma Express: Bridging the Emergency to Primary Care in Underserved Children

Johns Hopkins University

NCT01981564

COMPLETED NA 221 participants

Text2Breathe: Enhance Parent Communication to Reduce Pediatric Asthma Disparities

Seattle Children's Hospital

NCT03032159

COMPLETED Phase 3 220 participants

Teaching Children With Asthma and Who Live in a Rural Setting How to Self-Manage Their Asthma

National Institute of Nursing Research (NINR)

NCT00218803

COMPLETED Phase 3 211 participants

Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma

AstraZeneca

NCT02322775

COMPLETED Phase 2 211 participants

Characterization of the Role of Histamine in Children With Asthma

Children's Mercy Hospital Kansas City

NCT01392859

COMPLETED Phase 2 208 participants

Study of MAP0010 in Asthmatic Children and Adolescents

Allergan

NCT00697801

COMPLETED 208 participants

Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy

National Institute of Allergy and Infectious Diseases (NIAID)

NCT02502890

COMPLETED NA 203 participants

Environmental Tobacco Smoke Exposure Reduction in High-Risk Preteens

San Diego State University

NCT00217893

COMPLETED Phase 2 203 participants

TC-6987 for the Treatment of Mild to Moderate Asthma

Targacept

NCT01296087

COMPLETED Phase 4 202 participants

A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent Asthma

Sanofi

NCT04502862

COMPLETED Phase 2 200 participants

Control of Asthma Patients Symptomatic on Inhaled Corticosteroids

Inflazyme Pharmaceuticals

NCT00330070

COMPLETED Phase 2 198 participants

Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma

GlaxoSmithKline

NCT00843193

COMPLETED NA 188 participants

A Community Health Worker Home Intervention to Improve Pediatric Asthma Outcomes

Montefiore Medical Center

NCT01003340

COMPLETED NA 187 participants

Quality IQ Patient Simulation Physician Practice Measurement and Engagement

Qure Healthcare

NCT03800901

COMPLETED NA 185 participants

Developing and Implementing Asthma-Guidance and Prediction System (a-GPS) for Better Asthma Management

Mayo Clinic

NCT02865967

COMPLETED Phase 2 184 participants

A Study of ARRY-502 in Patients With Persistent Asthma

Pfizer

NCT01561690

COMPLETED NA 176 participants

The Genetics of Environmental Asthma

National Institute of Environmental Health Sciences (NIEHS)

NCT00018096

COMPLETED NA 172 participants

Remote Physician Care for Home Hospital Patients

Brigham and Women's Hospital

NCT04080570

COMPLETED 171 participants

Longitudinal Observational Study of Severe Asthma

National Heart, Lung, and Blood Institute (NHLBI)

NCT01780142

COMPLETED 171 participants

Characterization of Adults for Asthma Microbiome Research Studies

University of Michigan

NCT02887911

COMPLETED Phase 1 168 participants

T Cell Effector and Regulatory Mechanisms in Asthma

Andrew D. Luster, M.D.,Ph.D.

NCT01612936

COMPLETED Phase 2 165 participants

Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma

GlaxoSmithKline

NCT03207243

COMPLETED Phase 3 162 participants

Study to Assess Functionality, Reliability, and Performance of a Pre-filled Syringe With Benralizumab Administered at Home

AstraZeneca

NCT02417961

COMPLETED Phase 2 155 participants

Environmental Control as Add-on Therapy in Childhood Asthma

Johns Hopkins University

NCT02251379

COMPLETED 153 participants

Segmental Bronchoalveolar Lavage

National Heart, Lung, and Blood Institute (NHLBI)

NCT00001618

COMPLETED NA 144 participants

Effects of Educational Intervention on Long-Term Outcomes of Hospitalized Children With Asthma

University of Louisville

NCT01447459

COMPLETED NA 142 participants

Video vs. TTG Respiratory Inhaler Technique Assessment and InstructioN (V-TRaIN)

University of Chicago

NCT02611531

COMPLETED NA 139 participants

Influence of Data Collection Mode on Self-Report Validity of Asthma Therapy Adherence

Johns Hopkins University

NCT00233233

COMPLETED Phase 3 135 participants

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

GlaxoSmithKline

NCT01691508

COMPLETED 131 participants

UTMB Research on Severe Asthma (UROSA) Study

The University of Texas Medical Branch, Galveston

NCT02264691

COMPLETED Phase 3 128 participants

A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited)

Sun Pharmaceutical Industries Limited

NCT03528577

COMPLETED NA 126 participants

Teen Asthma Project

University of Rochester

NCT01161225

COMPLETED Phase 3 121 participants

Study to Assess Functionality, Reliability, and Performance of a Single-Use Auto-Injector With Benralizumab Administered at Home

AstraZeneca

NCT02918071

COMPLETED NA 120 participants

Implementation of ACT Through Facebook for Teenagers With Asthma

Massachusetts General Hospital

NCT01675921

COMPLETED Phase 2 120 participants

Study Evaluating Etanercept in Moderate to Severe Asthma

Wyeth is now a wholly owned subsidiary of Pfizer

NCT00141791

COMPLETED NA 118 participants

Comparison of Breath-Enhanced and T-Piece Nebulizers in Children With Acute Asthma

Seton Healthcare Family

NCT02566902

COMPLETED Phase 2 118 participants

A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With Asthma

AstraZeneca

NCT06644924

COMPLETED 117 participants

Role of Cysteinyl Leukotrienes in the Pathogenesis of Asthma in Obesity

University of Michigan

NCT01158573

COMPLETED Phase 2 116 participants

A Study of the Safety and Effectiveness of JNJ-39758979 in the Treatment of Adults With Persistent Asthma

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

NCT00946569

COMPLETED 115 participants

Immune Interactions in Severe Asthma

University of Pittsburgh

NCT02566668

COMPLETED Phase 2 112 participants

A Study of the Safety and Efficacy of Tofimilast in Adult Asthmatics

Pfizer

NCT00150397

COMPLETED NA 112 participants

Vitamin D Oral Replacement in Asthma

IDeA States Pediatric Clinical Trials Network

NCT03686150

COMPLETED Phase 2 105 participants

Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate Asthma

Boehringer Ingelheim

NCT01122680

COMPLETED Early Phase 1 100 participants

The Leaky Lung Test

University of Rochester

NCT02306473

COMPLETED NA 99 participants

School-Based Preventive Asthma Care Technology: A Trial Using a Novel Technology to Improve Adherence

University of Rochester

NCT01175434

COMPLETED 99 participants

Molecular Phenotyping of Asthma in Sickle Cell Disease

Nemours Children's Clinic

NCT01879592

COMPLETED Phase 3 97 participants

AZMATICS: AZithroMycin/Asthma Trial In Community Settings

University of Wisconsin, Madison

NCT00266851

COMPLETED NA 95 participants

Asthma Data Innovation Demonstration Project

David Van Sickle

NCT02162576

← Previous Page 5 of 8 Next →

Phase Distribution

PhaseTrial count
Phase 1 27
Phase 2 81
Phase 3 51
Phase 4 38

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What is open for Asthma right now

70 recruiting of 378 indexed (19% open).

Phase mix: 89 late (III/IV) vs 108 early (I/II) (balanced across stages).

Top sponsor: GlaxoSmithKline (24 trials), 9 others listed. 50 shown below, recruiting first. #15 of 28,963 conditions by registered trial count.

How open-enrollment share is computed

Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.

Frequently Asked Questions

How many clinical trials are there for Asthma?

PlainTrial tracks 378 US clinical trials for Asthma, of which 70 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Asthma?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.